Literature DB >> 15229109

Human breast milk suppresses the transcriptional regulation of IL-1beta-induced NF-kappaB signaling in human intestinal cells.

Ryoko Minekawa1, Takashi Takeda, Masahiro Sakata, Masami Hayashi, Aki Isobe, Toshiya Yamamoto, Keiichi Tasaka, Yuji Murata.   

Abstract

Neonatal necrotizing enterocolitis (NEC), which is a disease with a poor prognosis, is considered to be caused by the coincidence of intestinal ischemia-reperfusion injury and systemic inflammation due to the colonization of pathogenic bacteria. Interleukin (IL)-8, a proinflammatory cytokine, plays an important role in the pathophysiology of NEC. It was recently reported that IL-1beta activates the IL-8 gene by regulating the transcriptional nuclear factor kappaB (NF-kappaB) signaling pathways in intestinal cells. The protective role of maternal milk in NEC pathogenesis has been reported in both human and animal studies. In this study, we show that human breast milk dramatically suppressed the IL-1beta-induced activation of the IL-8 gene promoter by inhibiting the activation pathway of NF-kappaB. Moreover, we also show that human breast milk induced the production of IkappaBalpha. These results suggest that human breast milk could be protective and therapeutic in neonates with NEC by inhibiting the activation pathway of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229109     DOI: 10.1152/ajpcell.00471.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  19 in total

Review 1.  Establishment of intestinal homeostasis during the neonatal period.

Authors:  Silvia Stockinger; Mathias W Hornef; Cécilia Chassin
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

Review 2.  Necrotising enterocolitis and localised intestinal perforation: different diseases or ends of a spectrum of pathology.

Authors:  V E Boston
Journal:  Pediatr Surg Int       Date:  2006-05-04       Impact factor: 1.827

Review 3.  Host factors in amniotic fluid and breast milk that contribute to gut maturation.

Authors:  Carol L Wagner; Sarah N Taylor; Donna Johnson
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

4.  Inflammatory signaling in NEC: Role of NF-κB, cytokines and other inflammatory mediators.

Authors:  Catherine J Hunter; Isabelle G De Plaen
Journal:  Pathophysiology       Date:  2013-12-31

Review 5.  Inflammatory signaling in necrotizing enterocolitis.

Authors:  Isabelle G De Plaen
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

6.  Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-κB leads to hyperbilirubinemia.

Authors:  Ryoichi Fujiwara; Shujuan Chen; Michael Karin; Robert H Tukey
Journal:  Gastroenterology       Date:  2011-10-06       Impact factor: 22.682

7.  Improving the use of human milk during and after the NICU stay.

Authors:  Paula P Meier; Janet L Engstrom; Aloka L Patel; Briana J Jegier; Nicholas E Bruns
Journal:  Clin Perinatol       Date:  2010-03       Impact factor: 3.430

8.  Cytokines and Toll-like receptor signaling pathways in the terminal ileum of hypoxic/hyperoxic neonatal rats: benefits of probiotics supplementation.

Authors:  Antoni D'Souza; Charles L Cai; Dharmendra Kumar; Fayme Cai; Lawrence Fordjour; Asma Ahmad; Gloria Valencia; Jacob V Aranda; Kay D Beharry
Journal:  Am J Transl Res       Date:  2012-04-10       Impact factor: 4.060

9.  Intestinal alkaline phosphatase administration in newborns decreases systemic inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model.

Authors:  Rebecca M Rentea; Jennifer L Liedel; Katherine Fredrich; Scott R Welak; Kirkwood A Pritchard; Keith T Oldham; Pippa M Simpson; David M Gourlay
Journal:  J Surg Res       Date:  2012-06-01       Impact factor: 2.192

Review 10.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.